1. Pink Sheet

Drug Promotion During Pandemic: Website Links To Telemedicine Prescribers Require Caution

 
• By Brenda Sandburg

Growing trend of linking product websites to telehealth services raises regulatory concerns. Virtual interactions with healthcare providers might necessitate new FDA guidance, lawyers note at FDLI annual meeting.

Telemedicine
Drug site links to telemedicine providers raise promotion compliance concerns • Source: Alamy

A significant trend during the COVID-19 pandemic has been industry’s growing use of telemedicine prescribers, which has raised concerns about ensuring compliance in the promotion of drug products.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Marketing & Advertising

More from Compliance